FDA wants sale of unapproved cold drugs stopped
Key points
- Adams Respiratory Therapeutics Inc. said U.S. health regulators asked companies to stop manufacturing and distributing unapproved timed-release dosage forms containing guaifenesin, used for treating cold and cough.
- Only Adams Respiratory has the Food and Drug Administration's approval to sell timed-release products containing guaifenesin, according to the regulator's Web site.
Adams Respiratory Therapeutics Inc. said U.S. health regulators asked companies to stop manufacturing and distributing unapproved timed-release dosage forms containing guaifenesin, used for treating cold and cough.
Only Adams Respiratory has the Food and Drug Administration's approval to sell timed-release products containing guaifenesin, according to the regulator's Web site.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Medicines & Treatments →Anti-Depressant Drugs Can Double Risk of Gastrointestinal Bleeding
New research shows that selective serotonin reuptake inhibitors (SSRIs), a group of drugs commonly used to treat depression, may double the risk of gastrointestinal bleeding, according to researchers from Wake Forest…
9 October 2007
